Skip to content

Daniel G Barrus

3 papers in the library · publishing 2016-2024

Papers

Sort Most recent Most cited

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 8, 2024 Jenny L Wiley, Julie A. Marusich, Bruce E. Blough et al.

The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9-Tetrahydrocannabinol (Δ9-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used...

Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Neuropharmacology July 15, 2018 Daniel G Barrus, Timothy W Lefever, Jenny L Wiley

Edible cannabis-infused products are an increasingly popular method of using cannabis in the United States. Yet, preclinical research to determine mechanisms underlying abuse of Δ9-tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis, has focused primarily on the effects of parenteral administration. The purpose of this study was to examine the rewarding and aversive...

DOI: 10.1016/j.neuropharm.2018.04.018 (opens in new tab) Full text (opens in new tab) Cannabinoid Delta-9-tetrahydrocannabinol Oral Self-administration +1

Tasty THC: Promises and Challenges of Cannabis Edibles

November 15, 2016 Daniel G Barrus, Kristen Capogrossi, Sheryl Cates et al.

Food products containing cannabis extract (edibles) have emerged as a popular and lucrative facet of the legalized market for both recreational and medicinal cannabis. The many formulations of cannabis extracts used in edibles present a unique regulatory challenge for policy makers. Though edibles are often considered a safe, discreet, and effective means of attaining the therapeutic and/or...